https://www.selleckchem.com/products/LBH-589.html
28 [95% CI, -11.89 to 5.34]; BIT-C WMD, 2.66 [95% CI, -10.35 to 11.67]; Catherine Bergego Scale WMD, -1.22 [95% CI, -3.05 to 0.62]). PA did not show a greater improvement on neglect symptoms in post-stroke patients with unilateral neglect, compared with placebo or no treatment. These findings do not support the routine use of PA in patients with unilateral neglect after stroke. PA did not show a greater improvement on neglect symptoms in post-stroke patients with unilateral neglect, compared with placebo or no treatment. These findings